Stratification, blinding and placebo effect in a randomized, double blind placebo-controlled clinical trial of gold bead implantation in dogs with hip dysplasia

Acta Veterinaria Scandinavica

Volumn 46, Issue 1-2, 2005, Pages 57-68

  Jæger, Gry T ^a,b   Larsen, S ^a,b   Moe, L ^b  

^a Department of Companion Animal Clinical Sciences ^*  (Norway)

^b NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

Author keywords

Canine; Hip dysplasia; Study design

Indexed keywords

CANIS FAMILIARIS;

ANTIRHEUMATIC AGENT; ORGANOGOLD COMPOUND;

AGE; ANIMAL; ARTICLE; BODY WEIGHT; CLASSIFICATION; DOG; DOG DISEASE; FEMALE; HOSPITALIZATION; MALE; PROSTHESES AND ORTHOSES;

AGE FACTORS; ANIMALS; ANTIRHEUMATIC AGENTS; BODY WEIGHT; DOGS; FEMALE; HIP DYSPLASIA, CANINE; MALE; ORGANOGOLD COMPOUNDS; PROSTHESES AND IMPLANTS; SEVERITY OF ILLNESS INDEX;

EID: 23944521358     PISSN: 0044605X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Agresti A: Categorical Data Analysis. John Wiley & Sons, New York, 1990.
2. Barr ARS, Denny HR, Gibbs C: Clinical hip dysplasia in growing dogs: the long-term results of conservative management. J. small Anim. Pract. 1987, 28, 243-252.
3. Batterman RC, Lower WR: Placebo responsiveness - influence of previous therapy. Curr. ther. Res. 1968, 10, 136-143.
4. Cardinet GH, III, Kass PH, Wallace LJ, Guffy MM: Association between pelvic muscle mass and canine hip dysplasia. J. Amer. vet. med. Ass. 1997, 210, 1466-1473.
5. Davis MA, Ettinger WH, Neuhaus JM, Cho SA, Hauck WW: The association of knee injury and obesity with unilateral and bilateral osteoarthritis of the knee. Amer. J. Epidemiol. 1989, 130, 278-288.
6. Durkes TE: Gold bead implants. Probl. vet. med. 1992, 4, 207-211.
7. Evans FJ: Expectancy, therapeutic instructions, and the placebo response. In: Placebo theory, research, and mechanisms (eds. White L, Tursky B, Schwartz GE). The Guildford Press, New York, 1985, pp. 215-228.
8. Feddersen-Petersen D: Some interactive aspects between dogs and their owner: are there reciprocal influences between both inter- and intraspecific communication? Appl. Anim. Behav. Sci. 1994, 40, 78.
9. Ferguson FR, Davey AFC, Topley WWC: The value of mixed vaccines in the prevention of the common cold. J. Hyg. 1927, 26, 98-109.
10. Gliedman LH, Gantt WH, Teitelbaum HA: Some implications of conditional reflex studies for placebo research. Amer. J. Psychiat. 1957, 113, 1103-1107.
11. Haygarth J: Of the imagination, as a cause and as a cure of disorders of the body: Exemplified by fictitious tractors, and epidemical convulsions. 1800. Bath: R. Crutwell. Available at: James Lind Library web site: http://www.jameslindlibrary. org/trial_records/19th_Century/haygarth/ haygarth_kp.html Accessed March 06, 2003.
12. Herrnstein RJ: Placebo effect in the rat. Science 1962, 138, 677-678.
13. Hielm-Bjorkman A, Raekallio M, Kuusela E, Saarto E, Markkola A, Tulamo RM: Double-blind evaluation of implants of gold wire at acupuncture points in the dog as a treatment for osteoarthritis induced by hip dysplasia. Vet. Rec. 2001, 149, 452-456.
14. Jœger GT, Larsen S, Søli N, Moe L: The pain relieving effect after six months of gold bead implantation in dogs suffering from hip dysplasia. A six months double blind, placebo-controlled study. 2004. Submitted.
15. Kealy RD, Lawler DF, Ballam JM, Lust G, Smith GK, Biery DN, Olsson SE: Five-year longitudinal study on limited food consumption and development of osteoarthritis in coxofemoral joints of dogs. J. Amer. vet. med. Ass. 1997, 210, 222-225.
16. Kleinbaum DG, Kupper LL, Muller KE, et al: Applied regression analysis and other multivariable methods. 3 ed. Brooks/Cole Publishing Company, Pacific Grove, 1998.
17. Lind J: A treatise on the scurvy. 2nd ed. London, 1757.
18. McMillan FD: The placebo effect in animals. J. Amer. vet. med. Ass. 1999, 215, 992-999.
19. Meinert C: Clinical Trials; Design, Conduct, and Analysis. Oxford University Press, New York, 1986.
20. Newton JO, Ehrlich W: Coronary blood flow in dogs: Effect of person. Cond. Reflex 1969, 4, 81-88.
21. Pavlov IP: Conditioned reflexes. Oxford Press, London, 1927.
22. Peck C, Coleman G: Implications of placebo theory for clinical research and practice in pain management. Theor. Med. 1991, 12, 247-270.
23. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br. J. Cancer 1976, 34, 585-612.
24. Phil RO, Altman J: An experimental analysis of the placebo effect. J. clin. Pharmacol. new Drugs 1971, 11, 91-95.
25. Pocock SJ: Methods of Randomization. In: Clinical Trials, A practical Approach. John Wiley & Sons, Chichester, 1983, pp. 66-89.
26. Riley V: Psychoneuroendocrine influences on immunocompetence and neoplasia. Science 1981, 212, 1100-1109.
27. Riser WH: The dysplastic hip joint: its radiographic and histologic development. J. Amer. vet. Radiol. Soc. 1973, 14, 35-50.
28. Riser WH, Shirer JF: Correlation between canine hip dysplasia and pelvic muscle mass: A study of 95 dogs. Amer. J. vet. Res. 1967, 28, 769-777.
29. Smith GK, Mayhew PD, Kapatkin AS, McKelvie PJ, Shofer FS, Gregor TP: Evaluation of risk factors for degenerative joint disease associated with hip dysplasia in German Shepherd Dogs, Golden Retrievers, Labrador Retrievers, and Rottweilers. J. Amer. vet. med. Ass. 2001, 219, 1719-1724.
30. Whittington K, Banks WC, Carlson WD, Hoerlein BF, Husted PW: Report of panel on canine hip dysplasia. J. Amer. vet. med. Ass. 1961, 139, 791-806.